The actinomycins are yellow-red crystalline antibiotics that are produced by various species of Streptomyces. Streptomyces is a genus of soil microbes that, on the basis of its morphology, has a position between the fungi and the bacteria.
During the last few years we have been investigating the structure of the actinomycins. In the course of these studies, we have been able to clarify the constitution of some of them, and to find a method for their synthesis. A brief account of this worka will be given here.
Strains of Streptomyces able to synthesize actinomycins usually produce several actinomycins simultaneously. These mixtures of actinomycins form mixed crystals, and cannot be separated by fractional crystallization. In the early investigations, these mixtures were believed to be homogeneaus substances. Methods for the separation of such actinomycin mixtures by counter-current distribution or partition chromatography were first developed in our Institute 4 • By means of these methods, it was possible to separate small quantities of actinomycins and to identify them by their RF values. Moreover, it was then possible to obtain homogeneaus actinomycins in larger quantities, so that thereafter all experiments designed to clarify the structure of the actinomycins were on a sure basis. In the course of our investigations, we have isolated from different strains of Streptomyces nine crystalline actinomycins, and the total number has been raised to twentyfour by other workers.
The first chemical investigations carried out with mixtures of actinomycins by Todd, Johnson and co-workers 5 , as weil as by the author and co-workers 6 , showed that the molecule of the actinomycins consists of a polypeptide moiety and a part responsible for the yellow-red colour of the compounds. Thus the actinomycins are representatives of a new dass of natural products which can be named " chromopeptides ".
When homogeneaus actinomycins were at our disposal, we continued our work on their structure and decided to concentrate initially on one of the actinomycins, namely actinomycin Ca. By hydrolysis of actinomycin Ca with dilute and with concentrated hydrochloric acid, or with dilute sodium hydroxide, we obtained a number of degradation products, the structure ofwhich enabled us to propose 7 for actinomycin Ca the formula (1) . 
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The dotted line in formula (I) circumscribes the chromophore of actinomycin C 3 responsible for its yellow-red colour. This chromophore is the residue of the amino-phenoxazone-dicarboxylic acid (II) which we have named '' actinocin ''.
In the molecule of actinomycin C 3 (I), this actinocin (II) is linked by amide bonds derived from its two carboxyl groups to two identical peptide lactone groups. It is remarkable that these peptide groups contain four methylamino-acids, namely two molecules of sarcosine and two molecules of N-methyl-valine. It is also remarkable that the two molecules of alloisoleucine between the threonine and the proline have the " unnatural" D-configura tion.
Until recently, it could not be decided with certainty whether the carboxyl groups of the two N-methyl-valine residues at the end of each of the peptide chains were esterified with the threonine of the same peptide chain, as in formula (1), or with the hydroxyl group ofthe threonine ofthe other peptide chain. This alternative is demonstrated by the two simplified formulae (I II) and (IV) 0 To decide between these two formulae, we tried to split the chromophore into two parts without opening the lactone rings. If structure (111) were correct, such a degradation would give two fission products (V) each containing one of the peptide lactone rings of the original actinomycins. The groupings R 1 and R 2 linked to the peptide lactone groups represent fragments of the chromophoreo The isolation of only one of these fission products would suffice to establish the correctness of the structure (I II) 0 On the other hand, if the actinomycin were correctly represented by (IV), the envisaged fission of the chromophore would give a monocyclic degradation product (VI), in which the ring would contain two peptide units and two lactone groupso
A fission of the chromophore which did not harm the peptide groups was achieved by oxidation of desamino-actinomycin Ca (VII), a derivative which can be obtained in nearly quantitative yield by mild hydrolysis of actinomycin Ca (I) with dilute hydrochloric acid. Treatment of desaminoactinomycin C 3 (VII) with hydrogen peroxide in acetic acid yielded a colourless crystalline degradation product which was shown to have the structure (VIII). In other words, the degradation product contains one intact peptide lactone group of the actinomycin Ca, thus proving that actinomycin Ca has two peptide lactone groups 8 , as shown in formula (VII).
The structure of the actinomycin Ca, in particular the fact that it contains two identical peptide groups, raises the question of how the actinomycins are synthesized in the cell. We arrived at a hypothesis for this biosynthesis from the results of experi~ ments on the synthesis of the chromophore of actinomycin 0 3 • This chromophore can be produced 9 easily by oxidative condensation of two molecules of3-hydroxy-4-methylanthranilic acid (IX). A similar condensation is possible when the acid (IX) is linked via its carboxyl group to the amino group of an amino-acid, dipeptide, tripeptide, or tetrapeptide, as is indicated by the general formulae (XI) and (XII). In this ~ay, we were able to synthesize a number of actinocinyl-peptides of the general formula (X_II) from precursors similar to (XI). The observation that these condensations can be carried out in water at pH 7 ·8 with air as an oxidant, led us to the assumption 7 peptide groups, the cell should be able to synthesize four different actinomycins: two with identical and two with different peptide groups. How far this prediction is in accordance with the experimental findings will be discussed la ter. After the structure of actinomycin Ca had been determined, we turned our attention to the question ofhow the other actinomycins differ from actinomycin Ca. As has already been mentioned, strains of Streptomyces able to synthesize actinomycins usually produce a mixture of different actinomycins. An investigation of the actinomycin mixtures of twenty-one strains showed us that these strains can be classified into three groups according to the composition of their actinomycin mixtures. One of these groups produces an actinomycin mixture, designated with the Ietter C, that contains the actinomycins C 3 and C 2 as main components and actinomycin C 1 in smaller amounts.
By means of the same degradation methods as those 10 employed for the investigation of actin0mycin Ca, we were also able to establish the structures of actinomycins C 1 groups. For discussion of these differences it will be convenient to simplify the structural formulae in the manner which is illustrated in the case of actinomycin Ca (I) by formula (XV). The chromophore is symbolized by a horizontal line, and the amino and carbonyl group associated with it by two short diagonal dashes. The roman capitals indicating the configuration of the amino-and methylamino-acids are omitted, and the Iactone bond between the N-methyl-valine and the threonine is represented by a short dash.
Actinomycin C 1 (XVII) differs from actinomycin Ca (XV) only in that it contains two molecules of valine (XVIII) instead of two molecules of allo-. isoleueine (XIX). In this connection it should be noted that, on the basis of degradation experiments, Johnson and Bullock 12 concluded that actinomycin D ( described for the first time in 1954 by Waksman and Vining 1 3) also has the constitution (XVII). This proves unequivocally that actinomycin D is identical with our actinomycin C 1 , which was first described in 1952. Moreover, one of the three groups of actinomycin-producing strains mentioned above is characterized by the fact that it produces an actinomycin mixture containing predominantly actinomycin C 1 • Actinomycin C 2 (XVI) holds an intermediate position between actinomycin C 1 and Ca. One of its peptide groups has the same structure as the peptide groups of actinomycin Ca (XV) and the other as the peptide groups of actinomycin C 1 (XVII).
At first we could not eliminate the possibility that actinomycin C 2 (XVI) is a mixture of two isomers, one having the valine and allo-isoleucine in the positions shown in formula (XVI), and the other having the positions of these units interchanged as indicated by the serpentine line of formula (XVI). Recently, however, we have been able to show by degradation experiments (not discussed here) that actinomycin c2 is homogeneaus and not a mixture of two isomers. According to our hypothesis of the biosynthesis of the actinomycins, those strains of Streptomyces which produce actinomycins C 1 , C 2 and Ca simultaneously, would need two precursors for this synthesis. One of them (XXI) has n-valine, and the other (XX) has n-allo-isoleucine, in the peptide group. Oxidative condensation of two molecules of the precursor (XXI) would give actinomycin C 1 (XXIII). Analogaus condensation of two molecules of the precursor (XX) would give actinomycin Ca (XXII). On the other hand, if one molecule of the precursor (XX) is condensed with one molecule of the precursor (XXI), the formation of two isomers is to be expected, one that has the valine in the left-hand peptide group and the allo-isoleucine in the right-hand peptide group as in the formula (XXV), and the other with the positions of these two acids reversed as in formula (XXIV). One* of these two isomers is actinomycin c2.
An indication of the existence of the second isomer is given by an actinomycin which we have isolated from Streptomyces cultures producing actinomycins C 1 , C 2 and 0 3 • This new compound, which we have named 14 actinomycin C 2 a, and which differs only slightly in its RF value from actinomycin C 2 , contains the same amino and methylamino acids as actinomycin C 2 • Up to now we have obtained only small quantities of this new actinomycin, so that wehavenot as yet been able to determine the exact structure of its peptide groups. But, in all probability, actinomycin C 2 a is the isomer of actinomycin C 2 whose existence is to be expected on the basis of our hypothesis.
As already mentioned, all strains of Streptomyces investigated in our Institute can be classified into three groups according to the composition of their actinomycin complexes. It will be recalled that one of these groups produces a mixture of the actinomycins C 1 , C 2 and Ca, and another group a mixture containing mainly actinomycin C 1 • The third group synthesizes an actinomycin mixture that we have designated with the Ietter X 4 • 15 • This mixture consists of a main component, named actinomycin X 2 , and a nurober of other actinomycins, among them actinomycin C 1 • W e have shown that all components of the actinomycin mixture X have the same chromophore as actinomycins C 1 , C 2 and Ca. Consequently, they differ from each other, and from the C actinomycins, only in the structure of their peptide units.
Actinomycin X 2 , the main component of the actinomycin complex X, is characterized by the fact that it contains one molecule of L-y-oxo-proline 16 (XXVIII). Two other components contain L-:hydroxy-proline (XXX) or L-allo-hydroxy-proline (XXIX). The y-oxo-proline (XXVIII) is a derivative of proline that was unknown before 1956. I t was first synthesized by
*This has now been:shown to be (XXV) 33 • Kuhn and Osswald 17 • These authors showed that y-oxo-proline-in the form of carbethoxy-oxo-proline-ethylester-is reduced to proline by cata1ytic hydrogenation in acetic acid, and to allo-hydroxy-proline by catalytic hydrogenation in methanol. If, on the other band, the reduction is carried out with aluminium iso-propylate, a mixture of the hydroxy-proline and allo-hydroxy-pro1ine derivatives is formed. Wehave found that actinomycin X 2 differs from actinomycin 0 1 (XXVI) in that it contains one molecule of L-y-oxo-proline (XXVIII) in place of one molecule ofL-proline (XXVII). Actinomycin X 0 / 8 , another component of the actinomycin complex X, differs from actinomycin C 1 in that it contains one molecule of L-hydroxy-proline (XXX) in place of one molecule of proline (XXVII).
Finally, actinomycin X 08 19 , which can also be a component of the actino- acid over a platinum catalyst reduces actinomycin X 2 to actinomycin C 1 (XXXII), thus proving that actinomycin X 2 differs from actinomycin C 1 only in that it contains one molecule of L-y-oxo-proline in place of one molecule of L-proline 20 • Actinomycin x2 can thus be given the formula (XXXI).
Reduction by means of aluminium iso-propylate converted the actinomycin X 2 (XXXI) into actinomycin X 0 ß, whereas catalytic hydrogenation of actinomycin X 2 in methanol gave actinomycin X 08 • On the basis of these results the formulae (XXXIV) and (XXXIII) can be attributed to the actinomycins X 0 ß and X 08 respectively 20 • The serpentine line in these formulae as weil as in (XXXI) indicates that it is still uncertain whether the proline is apart of the left-hand or of the right-hand peptide group. According to the formulae (XXXIII) and (XXXIV), actinomycin X 0 ß isastereoisomer of actinomycin X 08 , differing from it only in the configuration ofthe hydroxyl-substituted carbon atom ofthe L-hydroxy-proline. This slight distinction is sufficient to cause a marked difference in the solubility of the two stereoisomers, and also in their antibiotic activity. For instance, actinomycin X 08 is about three times as soluble as actinomycin X 0 ß in methanol containing 5 per cent water, and it is about ten times as active Wehave found a new variation of the peptide moiety in two other components of the actinomycin complex X; we have named these 20 actinomycin X 0 y and actinomycin X 1 a. A comparison of their formulae ( (XXXV), (XXXVI) ) with that of actinomycin C 1 (XXXII) shows that actinomycin X 0 y (XXXV) can be considered as a derivative of actinomycin C 1 , one molecule of sarcosine being substituted for one molecule of proline. Likewise, actinomycin X 1 a (XXXVI) may be regarded as being a derivative of actinomycin C 1 , one molecule of sarcosine and one molecule of y-oxoproline being substituted for the two rnolecules of proline. The serpentine line in the formulae again indicates that the posit~ons of the proline and sarcosine, or of the oxo-proline and sarcosine, have not been ascertained and could in fact be the reverse ofthat shown. At this point it must be mentioned that Johnson and Mauger 21 have investigated an actinomycin, designated with the number III, and shown it to have the same amino-and methylamino-acids as actinomycin X 0 y. Whether our actinomycin X 0 y is identical with actinomycin III, or whether it is an isomer, remains to be established.
After the actinomycins had been shown to be chromopeptides, the question arose whether the actinomycin-producing organisms could be stimulated to incorporate into the actinomycin molecule amino-or methylamino-acids tha t had been added to the culture broth. Tha t this is indeed the case was demonstrated for the first time by Schmidt-Kastner 22 • After addition of either sarcosine or DL-isoleucine to the culture broth of strains producing actinomycin C 1 , C 2 and C 3 , he was able to isolate from the cultures a number of new actinomycins in addition to those normally formed.
In co-operation with Schmidt-Kastner, we have made quantitative determina tions of the amino-and methylamino-acids of the new actinomycins. Moreover, we have identified in their peptide groups those methylamino-acids that are esterified with the threonine residues. We cannot yet give an exact proof of any sequence of the amino-acids of the new actinomycins produced by the so-called " directed biosynthesis ". If, however, it is assumed that the " directed biosynthesis " is controlled by a tendency to make the structural differences between the actinomycins of the " directed biosynthesis" and the " normal" actinomycins as slight as possible, we arrive at the formulae (XXXVIII)-(XLIII).
The actinomycins E 1 (XXXVIII) and E 2 (XXXIX) are formed when DL-isoleucine is added to the culture broth of strains normally producing mixtures of the actinomycins C 1 , C 2 and Ca. As the formulae show, the addition of DL-isoleucine induces the strain to vary the molecule of actinomycin Ca by replacing one or both molecules of N-methyl-valine (XL) by N-methyl-isoleucine (XLI).
A second group of new actinomycins, named actinomycins F 1 , F 2 , Fa' F 4 and F 5 , was formed when sarcosine was added to the cul ture broth of strains "normally" producing the actinomycins C 1 , C 2 and Ca. The formulae of actinomycin Fa and F 4 are given by (XLIII) and (XLII) respectively. A comparison with the formula of actinomycin C 3 shows that the presence of sarcosine induces the cell to incorporate into the peptide groups one or two molecules of sarcosine instead of proline. In the same way the peptide groups of the actinomycin C 1 and C 2 can be varied by the cell.
Summarizing the above results on the structural differences of the peptide moiety of the actinomycins, one arrives at the following conclusions. In all actinomycins that we have investigated, the two carboxyl groups of the chromophore, which in all actinomycins has the same structure, are bonded to the amino group of two molecules of threonine. Variations in the structure of the peptide groups have been found in three constituents of these peptide groups, as is shown by (XLIV). The latter is the simplified formula of one of the two peptide groups of the actinomycin C 1 • These groups may be regarded as the " basic structure " of an actinomycin peptide group. This "basic structure" can be varied at the valine and at the N-methylvaline positions by substitution of a methyl group for a hydrogen atom at c(4)• By this Substitution the valine is converted into allo-isoleucine and the N-methyl-valine to N-methyl-isoleucine; variations of this type are possible in either or both of the peptide groups.
The proline residue can be varied firstly by the substitution of a hydroxyl group for one of the two hydrogen atoms at the y-carbon atom, and secondly by the substitution of a carbonyl oxygen atom for the two hydrogen atoms at the y-carbon atom of the proline. Finally, one or two molecules of sarcosine can be substituted for molecules of proline; in other words, the -CH 2 -CH 2 -group of the proline-see dashed line in formula (XLIV)-can be replaced by two hydrogen atoms.
Obviously there exist stillother variations of the peptide groups. Recently Keller-Schierlein 23 and co-workers have isolated five actinomycins, named actinomycin Z 1 , Z 2 , Z 3 , Z 4 and Z 5 , that all contain N-methyl-alanine. Some actinomycins similar to these have been isolated in our laboratory. Moreover, Katz and Goss 24 have described actinomycins containing pipecolic acid. These actinomycins were produced by the addition of pipecolic acid to the culture broth.
In view of the fact that, up to now, twenty-four different actinomycins have been isolated from Streptomyces cultures, it will naturally be asked whether there are marked differences in the cytostatic activity of these actinomycins. From animal experiments it was discovered that there are indeed such differences, although they do not appear to be significant. For this reason, we have attempted to obtain derivatives of actinomycins in the hope of finding one which has a better carcinolytic activity than the actinomycins. Derivatives of the actinomycins may be obtained in two ways: firstly, by modifying the peptide part, and secondly, by modifying the chromophore. Thus far, we have obtained derivatives in which the peptide part is modified only from the actinomycins X 0 p and X 08 , which, as already mentioned, contain hydroxy-proline or allo-hydroxy-proline. Both these actinomycins possess a free hydroxyl group (in either the hydroxy-proline or allo-hydroxyproline unit) which can be esterified with acids. On the assumption that -0
the hydroxy-proline or allo-hydroxy-proline is located in that peptide group which is bonded to the benzoid ring of the chromophore, the esters of actinomycin X 0 ,s and actinomycin X 08 may be represented by the formula (XL V), in which R represents the acid residue. With acetic acid and palmitic acid, we obtained the acetates and palmitates of actinomycins X 0 ,o and X 08 • These derivatives have less antibiotic and cytostatic activity than the parent actinomycins. Esterification was also effected with dicarboxylic acids, amino-acids and phosphoric acid. The esters thus obtained have a greater solubility in water than the actinomycins used as starting material, but their cytostatic activity has still to be determined. Except for a few cases still under investigation, the only modifications of the chromophore that we have been able to effect are associated with the amino group. The derivatives which we have obtained were prepared in a manner which is summarized by the formulae (XL VI)-(XL VIII). If an actinomycin (XLVI) is treated under mild conditions (four hours at 30°C) with 10 per cent hydrochloric acid, one molecule of ammonia is split off and a desamino-actinomycin (XL VII) is formed in almost quantitative yield 25 • During this process the peptide groups remain intact. In contrast to the actinomycins, the desamino-actinomycins have no toxic, antibiotic or cytostatic activity.
We have found that chlorine may be substituted for the hydroxyl group of the chromophore of the desamino-actinomycins (XL VII) by treatment with thionyl chloride. In this way crystalline antibiotically inactive chloroactinomycins (XLVIII) are obtained 26 • If a chloro-actinomycin is treated with ammonia, the original actinomycin is recovered 26 • The chloro-actinomycins can be treated with primary and secondary amines instead of ammonia 26 to yield actinomycin derivatives in which one (IL) or both of the hydrogen atoms of the amino group of the chromophore have been replaced by alkyl groups or other residues. In this way we have prepared a number of derivatives whose biological activity is still under investigation 27 ; (L)_:(LIII) are the formulae of four such derivatives. 
The dimethyl compound (LII) has only low antibiotic and carcinolytic actlvlty. The N-diethylamino-ethyl derivative (L) also has less antibiotic and cytostatic activity than actinomycin C 3 , but whether its therapeutic index is better than that of actinomycin Ca remains tobe determined. The same is true for the triazolyl derivative (LI). The most promising of the four derivatives seems to be N-dimethylene-actinomycin (LIII). In tumour experiments, its therapeutic index is better than that of the actinomycin C 3 , a result that has encouraged us to make this derivative available for clinical trials. Its antibiotic activity is less than that of the actinomycin C 3 , however. The modifications of the peptide groups and the chromophore described above are limited by the fact that all the reactions involved must be carried out under conditions which do not destroy the peptide groups or the chromophore. From the very beginning it was obvious that this Iimitation would be overcome if the actinomycins and their derivatives could be prepared by synthesis. During the last three years we have been attempting to achieve this, and very recently we have been successful in synthesizing actinomycin Ca.
Our first attempt to synthesize actinomycin Ca was based on the fact that the Iactone groups of the actinomycin Ca (LIV) are hydrolyzed by dilute sodium methoxide. The resulting actinomycin Ca acid can be given the formula (LV). From our work on the synthesis of actinocinyl-peptides, we had formed the opinion that it would not be too difficult to synthesize the actinomycin Ca acid (LV), which is an actinocinyl-bis-pentapeptide. Our plan, therefore, was to carry out such a synthesis, and then to cyclize the two peptide chains of the actinomycin Ca acid by esterification of the terminal carboxyl groups with the hydroxyl groups of the threonine residues. As this cyclization ~as expected to be the main difficulty in the synthesis, we decided to carry out an initial study with the actinomycin C 3 acid prepared from actinomycin Ca, and not with the precious synthetic material. However, experiments to prepare sufficient starting material for this purpose showed that the opening of the Iactone rings was accompanied by side reactions, and that the resultant by-products could not be separated easily.
While these experiments were under way, Dr Sunderkötter in our laboratory made an observation which opened up a new route for the synthesis of actinomycin Ca. By treating actinomycin Ca (LVI) with concentrated hydrochloric acid for four hours at 40°C, Sunderkötter obtained a degradation product which he found to have the formula (LVII)
•
This product we have named bis-seco-actinomycin Ca. Its formation shows that concentrated hydrochloric acid attacks the peptide chains of the actinomycin preferentially at the bond between sarcosine and the N-methyl-valine. On mild treatment with sodium hydroxide, the bis-seco-actinomycin Ca is converted into the actinocinyl-peptide (LVIII), which was synthesized in our laboratory by Lackner.
Bis-seco-actinomycin Ca (LVII), contains the tetrapeptide L-threonyln-allo-isoleucyl-L-prolyl-sarcosine, in which the amino group is blocked by a carboxyl group ofthe chromophore but in which the carboxyl group is free. In addition to this tetrapeptide, the bis-seco-actinomycin Ca contains N-methyl-valine with the methylamino group free but with the carboxyl group esterified with the hydroxyl group of the threonine residue. In other words, the molecule of bis-seco-actinomycin Ca contains the two reactive groups necessary for a peptide synthesis . . I benzylester (LXIV), and n-allo-isoleucine was formylated to give formyl-nallo-isoleucine (LXV). Coupling of the compound (LXIV) with the compound (LXV) by means of dicyclohexyl-carbodiimide yielded the compound (LXVI). The benzyl group was removed from the carboxyl group of this compound by catalytic hydrogenolysis, and the resulting formyl-n-allo-isoleucyl-proline (LXVII) was coupled with sarcosine benzylester (LXIX) (which was obtained from sarcosine by esterification with benzyl alcohol) to give the tripeptide derivative (LXX). Mild hydrolysis of this compound by means of hydrochloric acid in benzyl alcohol removed the formyl group from the amino group of the n-allo-isoleucine residue, thus giving n-allo-isoleucyl-L-prolyl-sarcosine benzylester (LXXI). This tripeptide ester (LXXI) was then coupled with the L-threonine derivative (LXIII) to give the compound (LXXII). The next step was the esterification of the hydroxyl group of the threonine residue in compound (LXXII) with N-carbobenzoxy-methyl-valine, a reaction that could not be Qc:*H,
(LXXIV) (LVII) product (LXXIV) thus formed was then oxidized by means of potassium ferricyanide in phosphate buffer at pH 7 ·3. In this way we obtained a mixture of different products from which we were able toseparate by means of partition chromatography a compound (LVII) that had the same RF value, the same spectrum, the same functional groups, and the same aminoand methylamino-acid content as the bis-seco-actinomycin prepared from actinomycin C 3 • The best proof of the identity of the two compounds, however, was the fact that, by treatm_ent with ethyl chloroformate, the synthetic compound (LVII) was converted into a crystalline, yellow-red, antibioti~ally active compound that was identical in every respect with actinomycin Ca (LVI). There is no doubt that the other actinomycins can be synthesized in the same way as actinomycin Ca. Moreover, it should now be possible to synthesize actinomycins and chromopeptides having chromophores and peptide parts different from those of the actinomycins we have at present. Perhaps among such compounds one will be found that has a better cytostatic activity than the actinomycins and actinomycin derivatives known at the present time.
